Condition: Distal Radius Fracture · Casting · Closed Reduction · Sponsor: Tampere University Hospital
DISCLOSE trial is a randomized controlled trial including 532 participants with low-energy distal radius fractures. The primary objective is to evaluate whether casting without prior closed reduction is equivalent to casting following closed reduction with respect to wrist-related pain and disability, as measured by the Patient-Rated Wrist Evaluation (PRWE) score at 12 months, in patients aged 65 years or older with a displaced distal radius fracture. * Primary endpoint will be PRWE at 12 months * Follow-up visits are scheduled at 3 and 12 months. 5-year follow-up will be considered as an exploratory endpoint
This description comes directly from the study's public registry record.
Laura Kärnä, MD · +3583311611 · laura.karna@pirha.fi
Ville Ponkilainen, MD, PhD · +3583311611 · ville@disclosetrial.com
Always discuss trial participation with your own doctor first.
| Viborg regional Hospital | Viborg, Denmark | Recruiting |
| Tartu University Hospital | Tartu, Estonia | Recruiting |
| Tampere University Hospital | Tampere, Pirkanmaa, Finland | Recruiting |
| Helsinki University Hospital | Helsinki, Uusimaa, Finland | Recruiting |
| Kanta-Häme Central Hospital | Hämeenlinna, Finland | Recruiting |
| Kuopio University Hospital | Kuopio, Finland | Recruiting |
| Oulu University Hospital | Oulu, Finland | Recruiting |
| Pori Central Hospital | Pori, Finland | Not Yet Recruiting |
| Turku University Hospital | Turku, Finland | Not Yet Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07042139